The blood group typing market is consolidated in nature due to the presence of a few large players. The prominent players in the market are Bio-Rad Laboratories, Inc. (U.S.), Grifols, S.A. (Spain), Immucor, Inc. (U.S.), Ortho Clinical Diagnostics, Inc. (U.S.), Quotient, Ltd. (U.S.), Novacyt Group (France), BAG Healthcare GmbH (Germany), Rapid Labs (U.K.), Day medical SA (Switzerland), DIAGAST (France), and AXO Science (France).
Bio-Rad Laboratories, Inc. was the largest player in the market in 2015 with its strong product portfolio for blood group typing. The company focuses on acquisitions to strengthen its position in the market. For instance, in February 2015, Bio-Rad Laboratories acquired GnuBIO Inc. (U.S.). This acquisition helped the company to expand its blood group typing portfolio. Such acquisitions enabled the company to increase its product portfolio in the market. The company is also focused on expansion activities to increase its global presence.
Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=72074095
Ortho Clinical Diagnostics, Inc. was the second-largest player in the market in 2015. The company focuses on expansions and on developing technologically advanced blood group typing products to strengthen its position in the market. The company adopts organic growth strategies such as product launches to strengthen its presence in the global blood group typing market.
Immucor, Inc. was the third-largest player in the market in 2015. The company offers a wide range of blood group typing products used in various healthcare applications. It has a strong geographic reach while offering its products to hospitals, reference laboratories, and donor centers. The company adopts inorganic growth strategies in order to sustain its leadership in the blood group typing market. Immucor recently acquired Sirona Genomics, Inc. (U.S.), to develop and commercialize the NGS system for high-resolution HLA typing.
The key strategies followed by most companies in the market are product launches and acquisitions. Bio-Rad Laboratories, Inc. (U.S.), Quotient, Ltd. (U.S.), Immucor, Inc. (U.S.), BAG Healthcare GmbH (Germany), and Ortho Clinical Diagnostics, Inc. (U.S.) are some of the major players operating in the blood group typing market.
The blood group typing market is projected to reach $3.12 billion by 2021 from $1.95 billion in 2016, at a CAGR of 9.8%. The market is segmented based on product & service, technique, test type, end user, and region.
Know More: https://www.marketsandmarkets.com/Market-Reports/blood-group-typing-market-72074095.html
